Peter Fellner Joins Astex as Chairman
16. April 2002 02:33 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., April 16, 2002 (PRIMEZONE) -- Astex Technology, the U.K. structure-based drug discovery company, today announced the appointment of Peter Fellner as non-executive Chairman of the...
Astex Announces Structure-Based Drug Discovery Collaboration with Aventis Pharmaceuticals
25. März 2002 02:31 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., March 25, 2002 (PRIMEZONE) -- Astex Technology, the private, structure-based drug discovery company, today announced a structural biology research agreement with Aventis...
Astex Receives Milestone Payment from AstraZeneca for Human Cytochrome P450 Program
25. März 2002 02:15 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., March 25, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, announced today that it has received the first milestone payment from AstraZeneca AB, as...
Astex Appoints Director of Biophysics
20. Februar 2002 03:30 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Feb. 20, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography technology, today announced the...
Astex Announces Plans for New, Purpose-Built Facility on Cambridge Science Park
23. Januar 2002 07:46 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Jan. 23, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography technology, today announced the...
Astex Raises an Additional 5.7m Pounds -- $8.1m US Dollars
17. Dezember 2001 05:11 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Dec. 17, 2001 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography (HTX(tm)) technology, today...
Astex Solves First Structure of a Human Cytochrome P450, A Key Enzyme in Drug Metabolism and Toxicity
17. Dezember 2001 04:54 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Dec. 17, 2001 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography (HTX(tm)) technology, today...
Astex Technology Appoints Jon S. Saxe to Board of Directors
20. November 2001 05:36 ET
|
Astex Therapeutics
CAMBRIDGE, UK, Nov. 20, 2001 (PRIMEZONE) -- Astex Technology, the UK structure-based drug discovery company, today announced the appointment of Jon Saxe to the Board.
Mr. Saxe was President of...